Short Interest in TherapeuticsMD, Inc. (NASDAQ:TXMD) Increases By 35.1%

TherapeuticsMD, Inc. (NASDAQ:TXMD) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 210,500 shares, a growth of 35.1% from the February 13th total of 155,800 shares. Based on an average daily volume of 531,500 shares, the days-to-cover ratio is currently 0.4 days. Currently, 1.9% of the company’s shares are sold short.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on TherapeuticsMD in a report on Tuesday, January 14th. They set a “hold” rating for the company.

TherapeuticsMD Trading Down 1.6 %

Shares of NASDAQ:TXMD opened at $0.73 on Friday. TherapeuticsMD has a 1 year low of $0.70 and a 1 year high of $2.61. The stock has a 50-day simple moving average of $1.00 and a 200-day simple moving average of $1.32.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.